Viewing StudyNCT01745120



Ignite Creation Date: 2024-05-06 @ 1:09 AM
Last Modification Date: 2024-10-26 @ 11:00 AM
Study NCT ID: NCT01745120
Status: COMPLETED
Last Update Posted: 2019-05-08
First Post: 2012-12-06

Brief Title: A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants
Sponsor: bluebird bio
Organization: bluebird bio

Conditions & Keywords Data

Conditions:
Name
β-thalassemia Major
Keywords:
Name View
gene therapy View
β thalassemia View
hemoglobin View
anemia View
CD34 View